Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mitoxantrone: benefits and risks in multiple sclerosis patients.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Flupirtine
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Repurposing drugs for disease modification in multiple sclerosis
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
Genzyme reports positive top-line results of TOWER, a pivotal phase III trial for AUBAGIO(TM*) (teriflunomide) in relapsing multiple sclerosis
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Treatment of neurological injury with thymosin β4.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up.
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Berlex continues legal challenge to FDA over MS drug.

Pages